Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA | Official Website
Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA | Official Website
This is an increase over the number of companies cited in the previous year.
The citations in the county include:
- The responsibilities and procedures applicable to the quality control unit are not in writing.
- Procedures for the cleaning and maintenance of equipment are deficient regarding sufficient detail of the methods, equipment, and materials used in the cleaning and maintenance operation, and the methods of disassembly and reassembling equipment as necessary to assure proper cleaning and maintenance.
- Establishment of the reliability of the component supplier's report of analyses is deficient in that the test results are not appropriately validated at appropriate intervals.
The company cited was involved in the Drugs sector.
The company cited had to take regulatory and/or administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
ABC Compounding Company, Inc. | Drugs | 04/21/2023 | Procedures not in writing, fully followed |
ABC Compounding Company, Inc. | Drugs | 04/21/2023 | Cleaning SOPs/instructions |
ABC Compounding Company, Inc. | Drugs | 04/21/2023 | Establish reliability of supplier's C of A |
ABC Compounding Company, Inc. | Drugs | 04/21/2023 | Control procedures to monitor and validate performance |
ABC Compounding Company, Inc. | Drugs | 04/21/2023 | Establishment of time limitations |
ABC Compounding Company, Inc. | Drugs | 04/21/2023 | Reprocessing procedures lack steps to be taken |
ABC Compounding Company, Inc. | Drugs | 04/21/2023 | Expiration date lacking |
ABC Compounding Company, Inc. | Drugs | 04/21/2023 | Scientifically sound laboratory controls |
ABC Compounding Company, Inc. | Drugs | 04/21/2023 | Drug products - samples representative, identified properly |
ABC Compounding Company, Inc. | Drugs | 04/21/2023 | Failing drug products not rejected |
ABC Compounding Company, Inc. | Drugs | 04/21/2023 | Sample size - test intervals |
ABC Compounding Company, Inc. | Drugs | 04/21/2023 | Written records kept in individual logs |